These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. A randomized prospective study of ceftazidime versus ceftazidime plus flucloxacillin in the empiric treatment of febrile episodes in severely neutropenic patients. de Pauw B, Williams K, de Neeff J, Bothof T, de Witte T, Holdrinet R, Haanen C. Antimicrob Agents Chemother; 1985 Dec; 28(6):824-8. PubMed ID: 3909956 [Abstract] [Full Text] [Related]
3. Ceftazidime with or without vancomycin vs. cephalothin, carbenicillin and gentamicin as the initial therapy of the febrile neutropenic pediatric cancer patient. Granowetter L, Wells H, Lange BJ. Pediatr Infect Dis J; 1988 Mar; 7(3):165-70. PubMed ID: 3282214 [Abstract] [Full Text] [Related]
4. Randomized trial of beta-lactam regimens in febrile neutropenic cancer patients. Anaissie EJ, Fainstein V, Bodey GP, Rolston K, Elting L, Kantarjian H, Cabanillas F, McCredie KB. Am J Med; 1988 Mar; 84(3 Pt 2):581-9. PubMed ID: 3279774 [Abstract] [Full Text] [Related]
5. Ceftazidime sodium carbonate versus ceftazidime arginine as empirical monotherapy in febrile neutropenic patients. Verhagen C, De Pauw BE, Williams KJ, Du Bois W. Eur J Clin Microbiol Infect Dis; 1988 Apr; 7(2):178-82. PubMed ID: 3134208 [Abstract] [Full Text] [Related]
6. Multicenter, randomized trial of ciprofloxacin plus azlocillin versus ceftazidime plus amikacin for empiric treatment of febrile neutropenic patients. Flaherty JP, Waitley D, Edlin B, George D, Arnow P, O'Keefe P, Weinstein RA. Am J Med; 1989 Nov 30; 87(5A):278S-282S. PubMed ID: 2686429 [Abstract] [Full Text] [Related]
7. Imipenem compared with ceftazidime plus vancomycin as initial therapy for fever in neutropenic children with cancer. Riikonen P. Pediatr Infect Dis J; 1991 Dec 30; 10(12):918-23. PubMed ID: 1766707 [Abstract] [Full Text] [Related]
8. A comparison of imipenem to ceftazidime with or without amikacin as empiric therapy in febrile neutropenic patients. Rolston KV, Berkey P, Bodey GP, Anaissie EJ, Khardori NM, Joshi JH, Keating MJ, Holmes FA, Cabanillas FF, Elting L. Arch Intern Med; 1992 Feb 30; 152(2):283-91. PubMed ID: 1739355 [Abstract] [Full Text] [Related]
9. [Prospective and comparative study of 2 antibiotic therapy protocols in 66 febrile neutropenic patients. Ceftazidime-vancomycin versus ticarcillin-vancomycin-amikacin]. Brion JP, Bru JP, Michallet M, Corron B, Fauconnier J. Presse Med; 1988 Oct 26; 17(37):1964-7. PubMed ID: 2973597 [Abstract] [Full Text] [Related]
10. [Antibiotic therapy protocol using ceftazidime 3g/day alone or in combination with vancomycin or amikacin. In febrile episodes in neutropenic patients]. Marie JP, Pico JL, Chiche D, Fitoussi F, Delmer A, Baume D, Rio B, Ajchenbaum F, Richet H, Tancrède C. Presse Med; 1988 Oct 26; 17(37):1968-70. PubMed ID: 2973598 [Abstract] [Full Text] [Related]
11. Three-step empiric treatment for severely neutropenic patients with fever: ceftazidime--vancomycin--amphotericin B. Koeppler H, Pflueger KH, Seitz R, Havemann K. Infection; 1989 Oct 26; 17(3):142-5. PubMed ID: 2661438 [Abstract] [Full Text] [Related]
12. Ceftazidime versus imipenem-cilastatin as initial monotherapy for febrile neutropenic patients. Liang R, Yung R, Chiu E, Chau PY, Chan TK, Lam WK, Todd D. Antimicrob Agents Chemother; 1990 Jul 26; 34(7):1336-41. PubMed ID: 2201252 [Abstract] [Full Text] [Related]
13. Vancomycin is not an essential component of the initial empiric treatment regimen for febrile neutropenic patients receiving ceftazidime: a randomized prospective study. Ramphal R, Bolger M, Oblon DJ, Sherertz RJ, Malone JD, Rand KH, Gilliom M, Shands JW, Kramer BS. Antimicrob Agents Chemother; 1992 May 26; 36(5):1062-7. PubMed ID: 1510394 [Abstract] [Full Text] [Related]
14. Randomized comparison between two ceftazidime-containing regimens and cephalothin-gentamicin-carbenicillin in febrile granulocytopenic cancer patients. Kramer BS, Ramphal R, Rand KH. Antimicrob Agents Chemother; 1986 Jul 26; 30(1):64-8. PubMed ID: 3530126 [Abstract] [Full Text] [Related]
15. Treatment of febrile episodes in neutropenic leukemic patients with the antibiotic combinations piperacillin or ceftazidime plus amikacin: results of a randomized study. Fenu S, Raccah R, Santilli S, Micozzi A, Girmena C, Martino P, Avvisati G. Chemioterapia; 1988 Oct 26; 7(5):323-6. PubMed ID: 3066517 [Abstract] [Full Text] [Related]
16. A prospective, randomized comparison of ceftazidime and ciprofloxacin as initial empiric therapy in neutropenic patients with fever. Bayston KF, Want S, Cohen J. Am J Med; 1989 Nov 30; 87(5A):269S-273S. PubMed ID: 2686428 [Abstract] [Full Text] [Related]
17. Comparison of two antibiotic regimens (piperacillin plus amikacin versus ceftazidime plus amikacin) as empiric therapy for febrile neutropenic patients with cancer. Feliu J, Artal A, González Barón M, Berrocal A, Chacón I, García de Paredes ML, Espinosa E, Ordóñez A, Zamora P, Montero JM. Antimicrob Agents Chemother; 1992 Dec 30; 36(12):2816-20. PubMed ID: 1482151 [Abstract] [Full Text] [Related]
18. [Ceftazidime for the treatment of infections in neutropenic children]. Leverger G, Arlet G, Bancillon A, Schaison G. Presse Med; 1988 Oct 26; 17(37):1974-6. PubMed ID: 2973600 [Abstract] [Full Text] [Related]
19. Cefepime versus ceftazidime as empiric monotherapy for fever and neutropenia in children with cancer. Chuang YY, Hung IJ, Yang CP, Jaing TH, Lin TY, Huang YC. Pediatr Infect Dis J; 2002 Mar 26; 21(3):203-9. PubMed ID: 12005083 [Abstract] [Full Text] [Related]
20. A randomized trial comparing ceftazidime alone with combination antibiotic therapy in cancer patients with fever and neutropenia. Pizzo PA, Hathorn JW, Hiemenz J, Browne M, Commers J, Cotton D, Gress J, Longo D, Marshall D, McKnight J. N Engl J Med; 1986 Aug 28; 315(9):552-8. PubMed ID: 3526155 [Abstract] [Full Text] [Related] Page: [Next] [New Search]